Applied DNA Sciences Inc (APDN)
2.51
-0.24
(-8.73%)
USD |
NASDAQ |
May 17, 16:00
2.51
0.00 (0.00%)
After-Hours: 20:00
Applied DNA Sciences Cash from Operations (Quarterly): -3.21M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.21M |
December 31, 2023 | -3.758M |
September 30, 2023 | -2.680M |
June 30, 2023 | -1.369M |
March 31, 2023 | 0.2144M |
December 31, 2022 | -2.383M |
September 30, 2022 | -3.259M |
June 30, 2022 | -1.754M |
March 31, 2022 | -0.2619M |
December 31, 2021 | -3.702M |
September 30, 2021 | -4.712M |
June 30, 2021 | -1.250M |
March 31, 2021 | -3.270M |
December 31, 2020 | -4.156M |
September 30, 2020 | -2.983M |
June 30, 2020 | -3.009M |
March 31, 2020 | -2.420M |
December 31, 2019 | -2.731M |
September 30, 2019 | -1.777M |
June 30, 2019 | -1.283M |
March 31, 2019 | -2.288M |
December 31, 2018 | -1.514M |
September 30, 2018 | -2.509M |
June 30, 2018 | -1.129M |
March 31, 2018 | -0.707M |
Date | Value |
---|---|
December 31, 2017 | -2.573M |
September 30, 2017 | -0.9139M |
June 30, 2017 | -1.866M |
March 31, 2017 | -2.630M |
December 31, 2016 | -2.069M |
September 30, 2016 | -2.446M |
June 30, 2016 | -2.227M |
March 31, 2016 | -2.503M |
December 31, 2015 | -2.721M |
September 30, 2015 | -1.739M |
June 30, 2015 | -1.255M |
March 31, 2015 | -1.616M |
December 31, 2014 | -2.356M |
September 30, 2014 | -2.242M |
June 30, 2014 | -2.008M |
March 31, 2014 | -2.196M |
December 31, 2013 | -2.066M |
September 30, 2013 | -2.173M |
June 30, 2013 | -1.808M |
March 31, 2013 | -2.149M |
December 31, 2012 | -1.740M |
September 30, 2012 | -0.9927M |
June 30, 2012 | -1.124M |
March 31, 2012 | -1.032M |
December 31, 2011 | -0.8115M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.712M
Minimum
Sep 2021
0.2144M
Maximum
Mar 2023
-2.488M
Average
-2.706M
Median
Cash from Operations (Quarterly) Benchmarks
Fonar Corp | 2.807M |
XWELL Inc | -3.201M |
ProPhase Labs Inc | -5.119M |
Veracyte Inc | -8.966M |
OncoCyte Corp | -3.83M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.0148M |
Cash from Financing (Quarterly) | 3.015M |
Free Cash Flow | -11.06M |
Free Cash Flow Per Share (Quarterly) | -3.701 |
Free Cash Flow to Equity (Quarterly) | -3.225M |
Free Cash Flow to Firm (Quarterly) | -3.225M |
Free Cash Flow Yield | -611.9% |